1.43
price up icon4.38%   0.06
after-market Dopo l'orario di chiusura: 1.46 0.03 +2.10%
loading

Ikena Oncology Inc Borsa (IKNA) Ultime notizie

pulisher
05:08 AM

Ikena Oncology shares fall 2.03% after-hours following acquisition by Inmagene Biopharmaceuticals. - AInvest

05:08 AM
pulisher
04:46 AM

Ikena Oncology Inc. Stock Analysis and ForecastExceptional profit margins - PrintWeekIndia

04:46 AM
pulisher
02:36 AM

Ikena Oncology shares climb as Kristin Yarema named CEO of soon-to-merge ImageneBio - MSN

02:36 AM
pulisher
12:49 PM

Ikena Oncology Completes Merger with Inmagene Biopharmaceuticals - TipRanks

12:49 PM
pulisher
11:16 AM

ImageneBio's Strategic Rebirth: A Catalyst for Long-Term Shareholder Value in the Atopic Dermatitis Market - AInvest

11:16 AM
pulisher
11:02 AM

Inmagene Biopharmaceuticals Announces Completion of Merger - GlobeNewswire

11:02 AM
pulisher
11:00 AM

Biotech Merger: Inmagene-Ikena Forms ImageneBio with $75M Backing from Elite Healthcare Investors - Stock Titan

11:00 AM
pulisher
09:48 AM

What analysts say about Ikena Oncology Inc. stockHigh-impact stock picks - PrintWeekIndia

09:48 AM
pulisher
07:29 AM

What drives Ikena Oncology Inc. stock priceExplosive trading opportunities - Autocar Professional

07:29 AM
pulisher
Jul 24, 2025

Ikena Oncology, Inc. SEC 10-Q Report - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

Ikena Oncology to implement 1-for-12 reverse stock split and rebrand as ImageneBio - Investing.com Nigeria

Jul 24, 2025
pulisher
Jul 24, 2025

Ikena Oncology to implement 1-for-12 reverse stock split and rebrand as ImageneBio By Investing.com - Investing.com South Africa

Jul 24, 2025
pulisher
Jul 24, 2025

Ikena Oncology Announces Reverse Stock Split and Rebrand - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Ikena to Rebrand as ImageneBio, Start 1-for-12 Reverse Split 28 Jul 2025 | IKNA SEC FilingForm 8-K - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Ikena Oncology and Inmagene Biopharmaceuticals Announce - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Kristin Yarema to lead merged Inmagene-Ikena entity - biocentury.com

Jul 23, 2025
pulisher
Jul 23, 2025

Ikena Oncology stock rises after naming Kristin Yarema as CEO of combined company - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company - The Manila Times

Jul 23, 2025
pulisher
Jul 23, 2025

Ikena Oncology and Inmagene name Kristin Yarema as CEO of combined firm By Investing.com - Investing.com South Africa

Jul 23, 2025
pulisher
Jul 23, 2025

Roche-Acquired Poseida CEO Takes Helm at Ikena-Inmagene Merger with $75M Funding - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

Ikena Oncology Announces Merger with Inmagene - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

IKNA issues special CVR dividend ahead of Inmagene merger | IKNA SEC FilingForm 8-K - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Is Ikena Oncology Inc. a good long term investmentBreakthrough stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

Ikena Oncology Approves Merger and Reverse Stock Split - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

Ikena Oncology amends executive agreement with Dr. Jotin Marango for equity vesting - Investing.com Nigeria

Jul 16, 2025
pulisher
Jul 16, 2025

Ikena Oncology amends executive agreement with Dr. Jotin Marango for equity vesting By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Ikena Oncology Updates Employment Terms Amid Merger Plans - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals - GlobeNewswire

Jul 16, 2025
pulisher
Jul 15, 2025

How Ikena Oncology Inc. stock performs during market volatilityIntraday Trade Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena Oncology announces stockholder approval of merger with Inmagene Biopharmaceuticals - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena shareholders approve merger with Inmagene, reverse stock split - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena announces 1-for-12 reverse stock split, approval of Inmagene merger - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena shareholders approve merger with Inmagene, reverse stock split By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena Oncology Approves Merger with Inmagene Biopharmaceuticals - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena Oncology Shareholders Green Light Inmagene Merger: What the 1-for-12 Split Means for Investors - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Why Ikena Oncology Inc. stock attracts strong analyst attentionFree Best Performing Stock Alerts - Newser

Jul 15, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):